Aphria Inc. Receives EU GMP Certification For Aphria One Facility

Aphria Inc. ("Aphria" or the "Company") ((APHA) today announced that it has received its European Union Good Manufacturing Practices ("EU GMP") certification as an active substance manufacturer in accordance with Art.111 of Directive 2001/83 EC from the Malta Medicines Authority ("MMA") at the Company's Aphria One facility in Leamington, Ontario.